ACADIA PHARMACEUTICALS INC — Director's Dealing 2013

Dec 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2013-12-17

Reporting Person: Hacksell Uli (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-17	Common Stock	M	6500	$1.55	Acquired	6500	Direct
2013-12-17	Common Stock	G	6500	—	Disposed	0	Direct
2013-12-17	Common Stock	G	6500	—	Acquired	115549	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-17	Stock Option (right to buy)	$1.55	M	6500	Disposed	2020-03-11	Common Stock (6500)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.